HCV Genotypes, Characterization of Mutations Conferring Drug Resistance to Protease Inhibitors, and Risk Factors among Blood Donors in São Paulo, Brazil
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HCV Genotypes, Characterization of Mutations Conferring Drug Resistance to Protease Inhibitors, and Risk Factors among Blood Donors in São Paulo, Brazil
Authors
Keywords
Hepatitis C virus, Viral load, Blood donors, Brazil, Blood transfusion, Protease inhibitors, Antimicrobial resistance, Substitution mutation
Journal
PLoS One
Volume 9, Issue 1, Pages e86413
Publisher
Public Library of Science (PLoS)
Online
2014-01-22
DOI
10.1371/journal.pone.0086413
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome-Wide Association Study of Spontaneous Resolution of Hepatitis C Virus Infection: Data From Multiple Cohorts
- (2013) Priya Duggal et al. ANNALS OF INTERNAL MEDICINE
- Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study
- (2013) Leila MMB Pereira et al. BMC INFECTIOUS DISEASES
- Genetic diversity of NS3 protease from Brazilian HCV isolates and possible implications for therapy with direct-acting antiviral drugs
- (2013) Allan Peres-da-Silva et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Variability and resistance mutations in the hepatitis C virus NS3 protease in patients not treated with protease inhibitors
- (2013) Luciana Bonome Zeminian et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Dynamics of resistance mutations to NS3 protease inhibitors in a cohort of Brazilian patients chronically infected with hepatitis C virus (genotype 1) treated with pegylated interferon and ribavirin: a prospective longitudinal study
- (2013) Luísa Hoffmann et al. Virology Journal
- Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy
- (2012) I. Vicenti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b
- (2012) Fumitaka Suzuki et al. JOURNAL OF CLINICAL VIROLOGY
- Genotyping and resistance profile of hepatitis C (HCV) genotypes 1–6 by sequencing the NS3 protease region using a single optimized sensitive method
- (2012) Bernard Besse et al. JOURNAL OF VIROLOGICAL METHODS
- Hepatitis C Virus Variants with Decreased Sensitivity to Direct-Acting Antivirals (DAAs) Were Rarely Observed in DAA-Naive Patients prior to Treatment
- (2012) Doug J. Bartels et al. JOURNAL OF VIROLOGY
- Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials
- (2012) Tara L. Kieffer et al. PLoS One
- Correlation of Viral Loads with HCV Genotypes: Higher Levels of Virus Were Revealed among Blood Donors Infected with 6a Strains
- (2012) Xia Rong et al. PLoS One
- Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus
- (2012) Cesar de Almeida-Neto et al. TRANSFUSION
- Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients
- (2012) Stefania Paolucci et al. Virology Journal
- Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California
- (2011) Paulo Telles Dias et al. BMC INFECTIOUS DISEASES
- Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus
- (2011) Jean-Michel Pawlotsky HEPATOLOGY
- Hepatitis C virus resistance to protease inhibitors
- (2011) Philippe Halfon et al. JOURNAL OF HEPATOLOGY
- Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal
- (2011) Rita Almeida Calado et al. JOURNAL OF MEDICAL VIROLOGY
- Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b
- (2011) J. Vermehren et al. JOURNAL OF VIRAL HEPATITIS
- An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region
- (2011) Tatsunori Nakano et al. LIVER INTERNATIONAL
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- A New Era of Hepatitis C Therapy Begins
- (2011) Donald M. Jensen NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations in hepatitis C virus NS3 protease domain associated with resistance to specific protease inhibitors in antiviral therapy naïve patients
- (2010) Allan Peres-da-Silva et al. ARCHIVES OF VIROLOGY
- Is sexual contact a major mode of hepatitis C virus transmission?
- (2010) Rania A. Tohme et al. HEPATOLOGY
- Epidemic history of Hepatitis C virus in Brazil
- (2010) Elisabeth Lampe et al. INFECTION GENETICS AND EVOLUTION
- Social Networks Shape the Transmission Dynamics of Hepatitis C Virus
- (2010) Camila Malta Romano et al. PLoS One
- Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
- (2009) Christoph Sarrazin et al. GASTROENTEROLOGY
- Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients
- (2009) Simone Susser et al. HEPATOLOGY
- Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil
- (2009) Maria de Lourdes Aguiar Oliveira et al. JOURNAL OF CLINICAL VIROLOGY
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
- (2009) David L. Thomas et al. NATURE
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative study of patients with chronic hepatitis C virus infection due to genotypes 1 and 3 referred for treatment in southeast Brazil
- (2008) Aline G Vigani et al. BMC INFECTIOUS DISEASES
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients
- (2008) Thomas Kuntzen et al. HEPATOLOGY
- Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in HIV‐Infected Patients with Anti‐HCV Antibodies in Europe
- (2008) Vincent Soriano et al. JOURNAL OF INFECTIOUS DISEASES
- Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive Subjects
- (2008) Doug J. Bartels et al. JOURNAL OF INFECTIOUS DISEASES
- Analysis of HCV resistance mutations during combination therapy with protease inhibitor boceprevir and PEG-IFN α-2b using TaqMan mismatch amplification mutation assay
- (2008) Stephanie Curry et al. JOURNAL OF VIROLOGICAL METHODS
- Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus
- (2008) Christoph Welsch et al. GENOME BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started